Association Between Bilirubin and Klotho Levels in US Middleaged and Older Adults: NHANES 2007-2016
Cunbao Ling1, Libing Tian1, Jielei Sun2
1School of Basic Medical Sciences, Jiangsu Vocational College of Medicine, Yancheng, Jiangsu, China.
Objective And Methods:
Bilirubin, a potent endogenous antioxidant, protects against multiple diseases. This cross-sectional study explored the relationship between Serum Total Bilirubin (STB) and Serum Klotho (S-Klotho, an anti-aging biomarker) in 40-79-year-olds from the 2007-2016 NHANES survey. Statistical analysis used a multivariable regression model; a Restricted Cubic Spline (RCS) model evaluated potential non-linear STB-S-Klotho associations. Subgroup analyses and sensitivity tests ensured the robustness.
Results:
The analysis included 4,562 individuals aged 40-79. Both unadjusted and adjusted models showed a significant positive association between STB and S-Klotho (β = 2.84, P = 0.02 in the weighted, fully adjusted model). The RCS curve indicated no significant non-linearity (P for non-linearity = 0.211). Subgroup analyses revealed stronger associations in females, normal-weight individuals, and those without diabetes mellitus (DM) or hypertension.
Discussion:
This is the first study exploring the STB-S-Klotho relationship. While human studies on bilirubin's role in aging have inconsistent conclusions, animal and mechanistic research show that elevated bilirubin reduces oxidative stress and inflammation, potentially protecting against age-related conditions.
Conclusion:
Our findings confirm a positive STB-S-Klotho correlation in middle-aged and older adults, suggesting bilirubin may be a potential S-Klotho biomarker and reflect biological aging processes.
Related Concept Videos
Jaundice
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Bioavailability: Influencing Factors
